Sign in
4

Changes in Ownership

IOVANCE BIOTHERAPEUTICS, INC. Filed Acc 0001250853-15-000045

Options or other derivatives

  • Chief Financial Officer acquired 200,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Henderson Molly · Chief Financial Officer

Table II: Derivative

1 line
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2015-06-08 Grant or award : show line 1 in the form Stock Option +200,000 $10.69 2025-06-07 200,000 200,000 D
Loading xslF345X03/primary_doc.xml…